Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview
Myeloproliferative neoplasms are caused by a clonal proliferation of a hematopoietic progenitor. First described in 1951 as ‘Myeloproliferative Diseases’ and reevaluated by the World Health Organization classification system in 2011, myeloproliferative neoplasms include polycythemia vera, essential...
Main Authors: | de Freitas, Renata Mendes, da Costa Maranduba, Carlos Magno |
---|---|
Format: | Online |
Language: | English |
Published: |
Sociedade Brasileira de Hematologia e Hemoterapia
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685044/ |
Similar Items
-
The JAK2 gene as a protagonist in chronic
myeloproliferative neoplasms
by: de Freitas, Renata Mendes, et al.
Published: (2013) -
Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms
by: Čokić, Vladan P., et al.
Published: (2015) -
Mouse models of myeloproliferative neoplasms: JAK of all grades
by: Li, Juan, et al.
Published: (2011) -
Coexistence of JAK2 and BCR-ABL mutation in patient with myeloproliferative neoplasm
by: Hassan, Abdulaziz, et al.
Published: (2015) -
JAK2 Inhibition: Reviewing a New Therapeutical Option in Myeloproliferative Neoplasms
by: Bellido, Mar, et al.
Published: (2012)